Optimization with levosimendan improves outcomes after left ventricular assist device implantation

Abstract

Levosimendan therapy was well-tolerated in patients who received permanent left ventricular assist devices. Combined preoperative therapy with inotropes and levosimendan significantly improves end-organ functions.